<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36145370</PMID><DateRevised><Year>2022</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1424-8247</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Pharmaceuticals (Basel, Switzerland)</Title><ISOAbbreviation>Pharmaceuticals (Basel)</ISOAbbreviation></Journal><ArticleTitle>Pharmacological Potential of Flavonoids against Neurotropic Viruses.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1149</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ph15091149</ELocationID><Abstract><AbstractText>Flavonoids are a group of natural compounds that have been described in the literature as having anti-inflammatory, antioxidant, and neuroprotective compounds. Although they are considered versatile molecules, little has been discussed about their antiviral activities for neurotropic viruses. Hence, the present study aimed to investigate the pharmacological potential of flavonoids in the face of viruses that can affect the central nervous system (CNS). We carried out research from 2011 to 2021 using the Pubmed platform. The following were excluded: articles not in the English language, letters to editors, review articles and papers that did not include any experimental or clinical tests, and papers that showed antiviral activities against viruses that do not infect human beings. The inclusion criteria were in silico predictions and preclinical pharmacological studies, in vitro, in vivo and ex vivo, and clinical studies with flavonoids, flavonoid fractions and extracts that were active against neurotropic viruses. The search resulted in 205 articles that were sorted per virus type and discussed, considering the most cited antiviral activities. Our investigation shows the latest relevant data about flavonoids that have presented a wide range of actions against viruses that affect the CNS, mainly influenza, hepatitis C and others, such as the coronavirus, enterovirus, and arbovirus. Considering that these molecules present well-known anti-inflammatory and neuroprotective activities, using flavonoids that have demonstrated both neuroprotective and antiviral effects could be viewed as an alternative for therapy in the course of CNS infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Castro E Silva</LastName><ForeName>Juliana Helena</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-8403-6016</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Health Sciences Institute, Federal University of Bahia, Salvador 40110-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souza</LastName><ForeName>Jéssica Teles</ForeName><Initials>JT</Initials><Identifier Source="ORCID">0000-0002-9688-2794</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Health Sciences Institute, Federal University of Bahia, Salvador 40110-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schitine</LastName><ForeName>Clarissa</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Health Sciences Institute, Federal University of Bahia, Salvador 40110-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Júnior</LastName><ForeName>Aníbal de Freitas Santos</ForeName><Initials>AFS</Initials><Identifier Source="ORCID">0000-0002-3022-0771</Identifier><AffiliationInfo><Affiliation>Department of Life Sciences, State University of Bahia, Salvador 41150-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastos</LastName><ForeName>Eduardo Muniz Santana</ForeName><Initials>EMS</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Health Sciences Institute, Federal University of Bahia, Salvador 40110-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Silvia Lima</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0002-8975-3871</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Health Sciences Institute, Federal University of Bahia, Salvador 40110-100, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>307539/2018-0</GrantID><Agency>National Council for Scientific and Technological Development</Agency><Country /></Grant><Grant><GrantID>88887.503664/2020-00</GrantID><Agency>Coordenação de Aperfeicoamento de Pessoal de Nível Superior</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pharmaceuticals (Basel)</MedlineTA><NlmUniqueID>101238453</NlmUniqueID><ISSNLinking>1424-8247</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antiviral</Keyword><Keyword MajorTopicYN="N">central nervous system infection</Keyword><Keyword MajorTopicYN="N">flavonoid</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>1</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36145370</ArticleId><ArticleId IdType="pmc">PMC9502241</ArticleId><ArticleId IdType="doi">10.3390/ph15091149</ArticleId><ArticleId IdType="pii">ph15091149</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stamatovic S.M., Johnson A.M., Keep R.F., Andjelkovic A.V. Junctional proteins of the blood-brain barrier: New insights into function and dysfunction. Tissue Barriers. 2016;4:e1154641. doi: 10.1080/21688370.2016.1154641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21688370.2016.1154641</ArticleId><ArticleId IdType="pmc">PMC4836471</ArticleId><ArticleId IdType="pubmed">27141427</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha M.K., Jo M., Kim J.H., Suk K. Microglia-Astrocyte Crosstalk: An Intimate Molecular Conversation. Neuroscientist. 2019;25:227–240. doi: 10.1177/1073858418783959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858418783959</ArticleId><ArticleId IdType="pubmed">29931997</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnihotri S.P. Central Nervous System Opportunistic Infections. Semin. Neurol. 2019;39:383–390. doi: 10.1055/s-0039-1687842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1687842</ArticleId><ArticleId IdType="pubmed">31378873</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal M., Berhanu G., Desalegn C., Kandi V. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update. Cureus. 2020;12:e7423. doi: 10.7759/cureus.7423.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.7423</ArticleId><ArticleId IdType="pmc">PMC7182166</ArticleId><ArticleId IdType="pubmed">32337143</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzišauskienė D., Vitkauskaitė M., Žvinytė K., Mameniškienė R. Neurological complications of pandemic A(H1N1)2009pdm, postpandemic A(H1N1)v, and seasonal influenza A. Brain Behav. 2020;11:e01916. doi: 10.1002/brb3.1916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1916</ArticleId><ArticleId IdType="pmc">PMC7821618</ArticleId><ArticleId IdType="pubmed">33155427</ArticleId></ArticleIdList></Reference><Reference><Citation>Soung A., Klein R.S. Viral Encephalitis and Neurologic Diseases: Focus on Astrocytes. Trends Mol. Med. 2018;24:950–962. doi: 10.1016/j.molmed.2018.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2018.09.001</ArticleId><ArticleId IdType="pmc">PMC6546292</ArticleId><ArticleId IdType="pubmed">30314877</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaewpoowat Q., Salazar L., Aguilera E., Wootton S.H., Hasbun R. Herpes simplex and varicella zoster CNS infections: Clinical presentations, treatments and outcomes. Infection. 2016;44:337–345. doi: 10.1007/s15010-015-0867-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-015-0867-6</ArticleId><ArticleId IdType="pubmed">26680781</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Riel D., Verdijk R., Kuiken T. The olfactory nerve: A shortcut for influenza and other viral diseases into the central nervous system. J. Pathol. 2015;235:277–287. doi: 10.1002/path.4461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4461</ArticleId><ArticleId IdType="pubmed">25294743</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Li Q., Bi K. shun Bioactive flavonoids in medicinal plants: Structure, activity and biological fate. Asian J. Pharm. Sci. 2018;13:12–23. doi: 10.1016/j.ajps.2017.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajps.2017.08.004</ArticleId><ArticleId IdType="pmc">PMC7032191</ArticleId><ArticleId IdType="pubmed">32104374</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa S.L., Silva V.D.A., Dos Santos Souza C., Santos C.C., Paris I., Muñoz P., Segura-Aguilar J. Impact of Plant-Derived Flavonoids on Neurodegenerative Diseases. Neurotox. Res. 2016;30:41–52. doi: 10.1007/s12640-016-9600-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-016-9600-1</ArticleId><ArticleId IdType="pubmed">26951456</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Pandey A.K., Lu K.P., Sastre J. Chemistry and Biological Activities of Flavonoids: An Overview. Sci. World J. 2013;2013:162750. doi: 10.1155/2013/162750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/162750</ArticleId><ArticleId IdType="pmc">PMC3891543</ArticleId><ArticleId IdType="pubmed">24470791</ArticleId></ArticleIdList></Reference><Reference><Citation>Youdim K.A., Qaiser M.Z., Begley D.J., Rice-Evans C.A., Abbott N.J. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic. Biol. Med. 2004;36:592–604. doi: 10.1016/j.freeradbiomed.2003.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2003.11.023</ArticleId><ArticleId IdType="pubmed">14980703</ArticleId></ArticleIdList></Reference><Reference><Citation>De Boer A.G., Gaillard P.J. Drug Targeting to the Brain. Annu. Rev. Pharmacol. Toxicol. 2007;47:323–355. doi: 10.1146/annurev.pharmtox.47.120505.105237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pharmtox.47.120505.105237</ArticleId><ArticleId IdType="pubmed">16961459</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueira I., Garcia G., Pimpão R.C., Terrasso A.P., Costa I., Almeida A.F., Tavares L., Pais T.F., Pinto P., Ventura M.R., et al. Polyphenols journey through blood-brain barrier towards neuronal protection. Sci. Rep. 2017;7:11456. doi: 10.1038/s41598-017-11512-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-11512-6</ArticleId><ArticleId IdType="pmc">PMC5597593</ArticleId><ArticleId IdType="pubmed">28904352</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayak M.K., Agrawal A.S., Bose S., Naskar S., Bhowmick R., Chakrabarti S., Sarkar S., Chawla-Sarkar M. Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses. J. Antimicrob. Chemother. 2014;69:1298–1310. doi: 10.1093/jac/dkt534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkt534</ArticleId><ArticleId IdType="pubmed">24458510</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu M., Xu L., Zhang M.-B., Chu Z.-Y., Wang Y.-D. Role of Baicalin in Anti-Influenza Virus A as a Potent Inducer of IFN-Gamma. BioMed Res. Int. 2015;2015:263630. doi: 10.1155/2015/263630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/263630</ArticleId><ArticleId IdType="pmc">PMC4689896</ArticleId><ArticleId IdType="pubmed">26783516</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Wang L. Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing miR-146a. Mol. Med. Rep. 2019;20:5041–5049. doi: 10.3892/mmr.2019.10743.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2019.10743</ArticleId><ArticleId IdType="pmc">PMC6854550</ArticleId><ArticleId IdType="pubmed">31638222</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghaddam E., Teoh B.-T., Sam S.-S., Lani R., Hassandarvish P., Chik Z., Yueh A., Abubakar S., Zandi K. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci. Rep. 2015;4:5452. doi: 10.1038/srep05452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep05452</ArticleId><ArticleId IdType="pmc">PMC4071309</ArticleId><ArticleId IdType="pubmed">24965553</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Liu Y., Wu T., Jin Y., Cheng J., Wan C., Qian W., Xing F., Shi W. The antiviral effect of baicalin on enterovirus 71 in vitro. Viruses. 2015;7:4756–4771. doi: 10.3390/v7082841.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7082841</ArticleId><ArticleId IdType="pmc">PMC4576202</ArticleId><ArticleId IdType="pubmed">26295407</ArticleId></ArticleIdList></Reference><Reference><Citation>Oo A., Rausalu K., Merits A., Higgs S., Vanlandingham D., Bakar S.A., Zandi K. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection. Antiviral Res. 2018;150:101–111. doi: 10.1016/j.antiviral.2017.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.12.012</ArticleId><ArticleId IdType="pubmed">29269135</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo S., Kim S., Shin D.H., Kim M.-S. Inhibition of SARS-CoV 3CL protease by flavonoids. J. Enzyme Inhib. Med. Chem. 2020;35:145–151. doi: 10.1080/14756366.2019.1690480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14756366.2019.1690480</ArticleId><ArticleId IdType="pmc">PMC6882434</ArticleId><ArticleId IdType="pubmed">31724441</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayem A.A., Choi H.Y., Kim Y.B., Cho S.G. Antiviral effect of methylated flavonol isorhamnetin against influenza. PLoS ONE. 2015;10:e0121610. doi: 10.1371/journal.pone.0121610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0121610</ArticleId><ArticleId IdType="pmc">PMC4373826</ArticleId><ArticleId IdType="pubmed">25806943</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadati S.M., Gheibi N., Ranjbar S., Hashemzadeh M.S. Docking study of flavonoid derivatives as potent inhibitors of influenza H1N1 virus neuraminidas. Biomed. Rep. 2019;10:33–38. doi: 10.3892/br.2018.1173.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2018.1173</ArticleId><ArticleId IdType="pmc">PMC6299203</ArticleId><ArticleId IdType="pubmed">30588301</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung P.Y., Ho B.C., Lee S.Y., Chang S.Y., Kao C.L., Lee S.S., Lee C.N. Houttuynia cordata targets the beginning stage of herpes simplex virus infection. PLoS ONE. 2015;10:e0115475. doi: 10.1371/journal.pone.0115475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0115475</ArticleId><ArticleId IdType="pmc">PMC4314066</ArticleId><ArticleId IdType="pubmed">25643242</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarwar M.W., Riaz A., Dilshad S.M.R., Al-Qahtani A., Nawaz-Ul-Rehman M.S., Mubin M. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease. BMC Struct. Biol. 2018;18:6. doi: 10.1186/s12900-018-0084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12900-018-0084-5</ArticleId><ArticleId IdType="pmc">PMC5909242</ArticleId><ArticleId IdType="pubmed">29673347</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou M., Liu H., Li J., Yao X., Chen Y., Ke C., Liu S. Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection. Biochem. Pharmacol. 2020;177:113962. doi: 10.1016/j.bcp.2020.113962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2020.113962</ArticleId><ArticleId IdType="pubmed">32272109</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber C., Sliva K., Von Rhein C., Kümmerer B.M., Schnierle B.S. The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection. Antiviral Res. 2015;113:1–3. doi: 10.1016/j.antiviral.2014.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.11.001</ArticleId><ArticleId IdType="pubmed">25446334</ArticleId></ArticleIdList></Reference><Reference><Citation>Carneiro B.M., Batista M.N., Braga A.C.S., Nogueira M.L., Rahal P. The green tea molecule EGCG inhibits Zika virus entry. Virology. 2016;496:215–218. doi: 10.1016/j.virol.2016.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.06.012</ArticleId><ArticleId IdType="pubmed">27344138</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim H., Nguyen T.T.H., Kim N.M., Park J.S., Jang T.S., Kim D. Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship. Biotechnol. Lett. 2017;39:415–421. doi: 10.1007/s10529-016-2261-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10529-016-2261-6</ArticleId><ArticleId IdType="pmc">PMC7088272</ArticleId><ArticleId IdType="pubmed">27885509</ArticleId></ArticleIdList></Reference><Reference><Citation>Henss L., Auste A., Schürmann C., Schmidt C., von Rhein C., Mühlebach M.D., Schnierle B.S. The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection. J. Gen. Virol. 2021;102:1574. doi: 10.1099/jgv.0.001574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001574</ArticleId><ArticleId IdType="pmc">PMC8290267</ArticleId><ArticleId IdType="pubmed">33830908</ArticleId></ArticleIdList></Reference><Reference><Citation>Keramagi A.R., Skariyachan S. Prediction of binding potential of natural leads against the prioritized drug targets of chikungunya and dengue viruses by computational screening. 3 Biotech. 2018;8:274. doi: 10.1007/s13205-018-1303-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13205-018-1303-2</ArticleId><ArticleId IdType="pmc">PMC5971020</ArticleId><ArticleId IdType="pubmed">29868312</ArticleId></ArticleIdList></Reference><Reference><Citation>Anusuya S., Gromiha M.M. Structural basis of flavonoids as dengue polymerase inhibitors: Insights from QSAR and docking studies. J. Biomol. Struct. Dyn. 2019;37:104–115. doi: 10.1080/07391102.2017.1419146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2017.1419146</ArticleId><ArticleId IdType="pubmed">29254451</ArticleId></ArticleIdList></Reference><Reference><Citation>Care C., Sornjai W., Jaratsittisin J., Hitakarun A., Wikan N., Triwitayakorn K., Smith D.R. Discordant activity of kaempferol towards dengue virus and Japanese encephalitis virus. Molecules. 2020;25:1246. doi: 10.3390/molecules25051246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25051246</ArticleId><ArticleId IdType="pmc">PMC7179415</ArticleId><ArticleId IdType="pubmed">32164193</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Xu C., Hao C., Zhang Y., Wang Z., Wang S., Wang W. Inhibition of herpes simplex virus by myricetin through targeting viral gD protein and cellular EGFR/PI3K/Akt pathway. Antiviral Res. 2020;177:104714. doi: 10.1016/j.antiviral.2020.104714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2020.104714</ArticleId><ArticleId IdType="pmc">PMC7111628</ArticleId><ArticleId IdType="pubmed">32165083</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling L., Lu Y., Zhang Y., Zhu H., Tu P., Li H., Chen D. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling. Phytomedicine. 2020;67:153150. doi: 10.1016/j.phymed.2019.153150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2019.153150</ArticleId><ArticleId IdType="pubmed">31958713</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji P., Chen C., Hu Y., Zhan Z., Pan W., Li R., Li E., Ge H.M., Yang G. Antiviral activity of Paulownia tomentosa against enterovirus 71 of hand, foot, and mouth disease. Biol. Pharm. Bull. 2015;38:1–6. doi: 10.1248/bpb.b14-00357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b14-00357</ArticleId><ArticleId IdType="pubmed">25744451</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W., Bi J., Li F., Wang S., Huang X., Meng X., Sun B., Wang D., Kong W., Jiang C., et al. Antiviral Efficacy of Flavonoids against Enterovirus 71 Infection in Vitro and in Newborn Mice. Viruses. 2019;11:625. doi: 10.3390/v11070625.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11070625</ArticleId><ArticleId IdType="pmc">PMC6669683</ArticleId><ArticleId IdType="pubmed">31284698</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohjala L., Utt A., Varjak M., Lulla A., Merits A., Ahola T., Tammela P. Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS ONE. 2011;6:e28923. doi: 10.1371/journal.pone.0028923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0028923</ArticleId><ArticleId IdType="pmc">PMC3242765</ArticleId><ArticleId IdType="pubmed">22205980</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.R., Jeong M.S., Mun S.H., Cho J., Seo M.D., Kim H., Lee J., Song J.H., Ko H.J. Antiviral activity of chrysin against influenza virus replication via inhibition of autophagy. Viruses. 2021;13:1350. doi: 10.3390/v13071350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13071350</ArticleId><ArticleId IdType="pmc">PMC8310364</ArticleId><ArticleId IdType="pubmed">34372556</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchinson E.C. Influenza Virus. Trends Microbiol. 2018;26:809–810. doi: 10.1016/j.tim.2018.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2018.05.013</ArticleId><ArticleId IdType="pubmed">29909041</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer F. Emerging influenza viruses and the prospect of a universal influenza virus vaccine. Biotechnol. J. 2015;10:690–701. doi: 10.1002/biot.201400393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biot.201400393</ArticleId><ArticleId IdType="pubmed">25728134</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Riel D., Leijten L.M., Verdijk R.M., GeurtsvanKessel C., Van Der Vries E., Van Rossum A.M.C., Osterhaus A.D.M.E., Kuiken T. Evidence for influenza virus CNS invasion along the olfactory route in an immunocompromised infant. J. Infect. Dis. 2014;210:419–423. doi: 10.1093/infdis/jiu097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu097</ArticleId><ArticleId IdType="pubmed">24550441</ArticleId></ArticleIdList></Reference><Reference><Citation>Murhekar M., Mehendale S. The 2015 influenza A (H1N1) pdm09 outbreak in India. Indian J. Med. Res. 2016;143:821–823. doi: 10.4103/0971-5916.192077.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-5916.192077</ArticleId><ArticleId IdType="pmc">PMC5094123</ArticleId><ArticleId IdType="pubmed">27748308</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewar S., Mirdha D., Rewar P. Treatment and Prevention of Pandemic H1N1 Influenza. Ann. Glob. Health. 2015;81:645–653. doi: 10.1016/j.aogh.2015.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aogh.2015.08.014</ArticleId><ArticleId IdType="pubmed">27036721</ArticleId></ArticleIdList></Reference><Reference><Citation>Enkhtaivan G., Maria John K.M., Ayyanar M., Sekar T., Jin K.J., Kim D.H. Anti-influenza (H1N1) potential of leaf and stem bark extracts of selected medicinal plants of South India. Saudi J. Biol. Sci. 2015;22:532–538. doi: 10.1016/j.sjbs.2015.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sjbs.2015.01.011</ArticleId><ArticleId IdType="pmc">PMC4537874</ArticleId><ArticleId IdType="pubmed">26288555</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Ni Y., Zhu L.-J., Wu F.-B., Yan F., Zhang X., Yao X.-S. Flavonoids from Matteuccia struthiopteris and Their Anti-influenza Virus (H1N1) Activity. J. Nat. Prod. 2015;78:987–995. doi: 10.1021/np500879t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/np500879t</ArticleId><ArticleId IdType="pubmed">25927664</ArticleId></ArticleIdList></Reference><Reference><Citation>Traboulsi H., Cloutier A., Boyapelly K., Bonin M.A., Marsault É., Cantin A.M., Richter M.V. The flavonoid isoliquiritigenin reduces lung inflammation and mouse morbidity during influenza virus infection. Antimicrob. Agents Chemother. 2015;59:6317–6327. doi: 10.1128/AAC.01098-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.01098-15</ArticleId><ArticleId IdType="pmc">PMC4576023</ArticleId><ArticleId IdType="pubmed">26248373</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Dou J., Su Z., Zhou H., Wang H., Zhou W., Guo Q., Zhou C. Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice. Antiviral Res. 2011;91:314–320. doi: 10.1016/j.antiviral.2011.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.07.008</ArticleId><ArticleId IdType="pubmed">21782851</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair M.S., Huang Y., Fidock D.A., Polyak S.J., Wagoner J., Towler M.J., Weathers P.J. Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants. J. Ethnopharmacol. 2021;274:114016. doi: 10.1016/j.jep.2021.114016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2021.114016</ArticleId><ArticleId IdType="pmc">PMC7952131</ArticleId><ArticleId IdType="pubmed">33716085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashiwada Y., Ahmed F.A., Kurimoto S.I., Kim S.Y., Shibata H., Fujioka T., Takaishi Y. New α-glucosides of caffeoyl quinic acid from the leaves of Moringa oleifera Lam. J. Nat. Med. 2012;66:217–221. doi: 10.1007/s11418-011-0563-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11418-011-0563-5</ArticleId><ArticleId IdType="pubmed">21748486</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiberger R., Radilová K., Kráľ M., Zima V., Majer P., Brynda J., Dračínský M., Konvalinka J., Kožíšek M., Machara A. Synthesis and In Vitro Evaluation of C-7 and C-8 Luteolin Derivatives as Influenza Endonuclease Inhibitors. Int. J. Mol. Sci. 2021;22:7735. doi: 10.3390/ijms22147735.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22147735</ArticleId><ArticleId IdType="pmc">PMC8305651</ArticleId><ArticleId IdType="pubmed">34299354</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J.-M., Lee K.-H., Seong B.-L. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005;68:66–74. doi: 10.1016/j.antiviral.2005.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2005.06.010</ArticleId><ArticleId IdType="pubmed">16137775</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong Y., Kim M., Ahn J., Oh H., Lim J., Chae W., Yang S.W., Kim M.S., Yu J.E., Byun S., et al. Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant. Front. Immunol. 2021;12:769088. doi: 10.3389/fimmu.2021.769088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.769088</ArticleId><ArticleId IdType="pmc">PMC8632720</ArticleId><ArticleId IdType="pubmed">34868027</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Wang Y., Jin J., Dou J., Guo Q., Ke X., Zhou C., Guo M. Inhibitory Activity of Honeysuckle Extracts against Influenza A Virus In Vitro and In Vivo. Virol. Sin. 2021;36:490–500. doi: 10.1007/s12250-020-00302-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00302-6</ArticleId><ArticleId IdType="pmc">PMC8257810</ArticleId><ArticleId IdType="pubmed">33044658</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Xue Q., Xu X. Involvement of the Nervous System in SARS-CoV-2 Infection. Neurotox. Res. 2020;38:1–7. doi: 10.1007/s12640-020-00219-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-020-00219-8</ArticleId><ArticleId IdType="pmc">PMC7220627</ArticleId><ArticleId IdType="pubmed">32399719</ArticleId></ArticleIdList></Reference><Reference><Citation>Paybast S., Emami A., Koosha M., Baghalha F. Novel coronavirus disease (COVID-19) and central nervous system complications: What neurologists need to know. Acta Neurol. Taiwan. 2020;29:24–31.</Citation><ArticleIdList><ArticleId IdType="pubmed">32285431</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen M.E., Eichel R., Steiner-Birmanns B., Janah A., Ioshpa M., Bar-Shalom R., Paul J.J., Gaber H., Skrahina V., Bornstein N.M., et al. A case of probable Parkinson’s disease after SARS-CoV-2 infection. Lancet Neurol. 2020;19:804–805. doi: 10.1016/S1474-4422(20)30305-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30305-7</ArticleId><ArticleId IdType="pmc">PMC7494295</ArticleId><ArticleId IdType="pubmed">32949534</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulzer D., Antonini A., Leta V., Nordvig A., Smeyne R.J., Goldman J.E., Al-Dalahmah O., Zecca L., Sette A., Bubacco L., et al. COVID-19 and possible links with Parkinson’s disease and parkinsonism: From bench to bedside. npj Parkinson’s Dis. 2020;6:18. doi: 10.1038/s41531-020-00123-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-020-00123-0</ArticleId><ArticleId IdType="pmc">PMC7441399</ArticleId><ArticleId IdType="pubmed">32885037</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416–427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J., Zhou F., Hou W., Silver Z., Wong C.Y., Chang O., Huang E., Zuo Q.K. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: A meta-analysis. Ann. N. Y. Acad. Sci. 2021;1486:90–111. doi: 10.1111/nyas.14506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.14506</ArticleId><ArticleId IdType="pmc">PMC7675607</ArticleId><ArticleId IdType="pubmed">33009668</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 “long haulers”. Ann. Clin. Transl. Neurol. 2021;8:1073–1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H.R., Yoon H., Kim M.K., Lee S.D., Chong Y. Synthesis and antiviral evaluation of 7-O-arylmethylquercetin derivatives against SARS-associated coronavirus (SCV) and hepatitis C virus (HCV) Arch. Pharm. Res. 2012;35:77–85. doi: 10.1007/s12272-012-0108-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12272-012-0108-9</ArticleId><ArticleId IdType="pmc">PMC7090976</ArticleId><ArticleId IdType="pubmed">22297745</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang F.R., Yen C.T., Ei-Shazly M., Lin W.H., Yen M.H., Lin K.H., Wu Y.C. Anti-human coronavirus (anti-HCoV) triterpenoids from the leaves of Euphorbia neriifolia. Nat. Prod. Commun. 2012;7:1415–1417. doi: 10.1177/1934578X1200701103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1934578X1200701103</ArticleId><ArticleId IdType="pubmed">23285797</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo S., Kim H., Kim S., Shin D.H., Kim M.S. Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors. Chem. Biol. Drug Des. 2019;94:2023–2030. doi: 10.1111/cbdd.13604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cbdd.13604</ArticleId><ArticleId IdType="pmc">PMC7162010</ArticleId><ArticleId IdType="pubmed">31436895</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo S., Kim S., Kim D.Y., Kim M.S., Shin D.H. Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro. J. Enzyme Inhib. Med. Chem. 2020;35:1539–1544. doi: 10.1080/14756366.2020.1801672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14756366.2020.1801672</ArticleId><ArticleId IdType="pmc">PMC7470085</ArticleId><ArticleId IdType="pubmed">32746637</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu A., Sarkar A., Maulik U. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2. Sci. Rep. 2020;10:17699. doi: 10.1038/s41598-020-74715-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-74715-4</ArticleId><ArticleId IdType="pmc">PMC7573581</ArticleId><ArticleId IdType="pubmed">33077836</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Zhang L., Xu Y., Yang D., Yang S., Zhang W., Wang J., Tian S., Yang S., Yuan T., et al. The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro. Biochem. Pharmacol. 2021;183:114302. doi: 10.1016/j.bcp.2020.114302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2020.114302</ArticleId><ArticleId IdType="pmc">PMC7588320</ArticleId><ArticleId IdType="pubmed">33121927</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Ye F., Sun Q., Liang H., Li C., Li S., Lu R., Huang B., Tan W., Lai L. Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro. J. Enzyme Inhib. Med. Chem. 2021;36:497–503. doi: 10.1080/14756366.2021.1873977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14756366.2021.1873977</ArticleId><ArticleId IdType="pmc">PMC7850424</ArticleId><ArticleId IdType="pubmed">33491508</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Yang R., Lee I., Zhang W., Sun J., Wang W., Meng X. Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors. Protein Sci. 2021;30:1114–1130. doi: 10.1002/pro.4075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.4075</ArticleId><ArticleId IdType="pmc">PMC8138525</ArticleId><ArticleId IdType="pubmed">33813796</ArticleId></ArticleIdList></Reference><Reference><Citation>Breitinger U., Ali N.K.M., Sticht H., Breitinger H.G. Inhibition of SARS CoV Envelope Protein by Flavonoids and Classical Viroporin Inhibitors. Front. Microbiol. 2021;12:692423. doi: 10.3389/fmicb.2021.692423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.692423</ArticleId><ArticleId IdType="pmc">PMC8297954</ArticleId><ArticleId IdType="pubmed">34305855</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornfeind E.M., Visalli R.J. Human herpesvirus portal proteins: Structure, function, and antiviral prospects. Rev. Med. Virol. 2018;28:e1972. doi: 10.1002/rmv.1972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1972</ArticleId><ArticleId IdType="pubmed">29573302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kukhanova M.K., Korovina A.N., Kochetkov S.N. Human herpes simplex virus: Life cycle and development of inhibitors. Biochemistry. 2014;79:1635–1652. doi: 10.1134/S0006297914130124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297914130124</ArticleId><ArticleId IdType="pubmed">25749169</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitley R.J. Herpes Simplex Virus Infections of the Central Nervous System. Contin. Lifelong Learn. Neurol. 2015;21:1704–1713. doi: 10.1212/CON.0000000000000243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000243</ArticleId><ArticleId IdType="pubmed">26633784</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoll M.P., Proença J.T., Efstathiou S. The molecular basis of herpes simplex virus latency. FEMS Microbiol. Rev. 2012;36:684–705. doi: 10.1111/j.1574-6976.2011.00320.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2011.00320.x</ArticleId><ArticleId IdType="pmc">PMC3492847</ArticleId><ArticleId IdType="pubmed">22150699</ArticleId></ArticleIdList></Reference><Reference><Citation>Vere Hodge R.A., Field H.J. Advances in Pharmacology. Vol. 67. Academic Press Inc.; Cambridge, MA, USA: 2013. Antiviral agents for herpes simplex virus; pp. 1–38.</Citation><ArticleIdList><ArticleId IdType="pubmed">23885997</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Wang Z., Yang Z., Wang J., Xu Y., Tan R., Li E. Houttuynia cordata blocks HSV infection through inhibition of NF-κB activation. Antiviral Res. 2011;92:341–345. doi: 10.1016/j.antiviral.2011.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.09.005</ArticleId><ArticleId IdType="pmc">PMC7114259</ArticleId><ArticleId IdType="pubmed">21951655</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Liu L., Wu H., Chen S., Zhu Q., Gao H., Yu X., Wang Y., Su W., Yao X., et al. Anti-herpes simplex virus type 1 activity of Houttuynoid A, a flavonoid from Houttuynia cordata Thunb. Antiviral Res. 2017;144:273–280. doi: 10.1016/j.antiviral.2017.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.06.010</ArticleId><ArticleId IdType="pubmed">28629987</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuchi K., Okudaira N., Adachi K., Odai-Ide R., Watanabe S., Ohno H., Yamamoto M., Kanamoto T., Terakubo S., Nakashima H., et al. Antiviral and antitumor activity of licorice root extracts. In Vivo. 2016;30:777–785. doi: 10.21873/invivo.10994.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.10994</ArticleId><ArticleId IdType="pubmed">27815461</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S., Sheng W.S., Schachtele S.J., Lokensgard J.R. Reactive oxygen species drive herpes simplex virus (HSV)-1-induced proinflammatory cytokine production by murine microglia. J. Neuroinflamm. 2011;8:123. doi: 10.1186/1742-2094-8-123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-123</ArticleId><ArticleId IdType="pmc">PMC3192693</ArticleId><ArticleId IdType="pubmed">21943001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahrs C.R., Chuda K., Tapia G., Stene L.C., Mårild K., Rasmussen T., Rønningen K.S., Lundin K.E.A., Kramna L., Cinek O., et al. Enterovirus as trigger of coeliac disease: Nested case-control study within prospective birth cohort. BMJ. 2019;364:1231. doi: 10.1136/bmj.l231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l231</ArticleId><ArticleId IdType="pmc">PMC6372922</ArticleId><ArticleId IdType="pubmed">30760441</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston L., Tapparel C. Rhinoviruses and respiratory enteroviruses: Not as simple as ABC. Viruses. 2016;8:16. doi: 10.3390/v8010016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8010016</ArticleId><ArticleId IdType="pmc">PMC4728576</ArticleId><ArticleId IdType="pubmed">26761027</ArticleId></ArticleIdList></Reference><Reference><Citation>Goksugur N., Goksugur S. Images in clinical medicine. Hand, foot, and mouth disease. N. Engl. J. Med. 2010;362:e49. doi: 10.1056/NEJMicm0910628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMicm0910628</ArticleId><ArticleId IdType="pubmed">20375401</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.M., Liu C.C., Tseng H.W., Wang J.R., Huang C.C., Chen Y.J., Yang Y.J., Lin S.J., Yeh T.F. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin. Infect. Dis. 1999;29:184–190. doi: 10.1086/520149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/520149</ArticleId><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.Y., Lin H.Y., Gau S.S.F., Lu C.Y., Hsia S.H., Huang Y.C., Huang L.M., Lin T.Y. Enterovirus A71 neurologic complications and long-term sequelae. J. Biomed. Sci. 2019;26:57. doi: 10.1186/s12929-019-0552-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0552-7</ArticleId><ArticleId IdType="pmc">PMC6688366</ArticleId><ArticleId IdType="pubmed">31395054</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney J.A., Mirsky D.M., Messacar K., Dominguez S.R., Schreiner T., Stence N.V. MRI Findings in Children with Acute Flaccid Paralysis and Cranial Nerve Dysfunction Occurring during the 2014 Enterovirus D68 Outbreak. AJNR Am. J. Neuroradiol. 2015;36:245–250. doi: 10.3174/ajnr.A4188.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4188</ArticleId><ArticleId IdType="pmc">PMC7965662</ArticleId><ArticleId IdType="pubmed">25414005</ArticleId></ArticleIdList></Reference><Reference><Citation>Majer A., McGreevy A., Booth T.F. Molecular Pathogenicity of Enteroviruses Causing Neurological Disease. Front. Microbiol. 2020;11:540. doi: 10.3389/fmicb.2020.00540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.00540</ArticleId><ArticleId IdType="pmc">PMC7161091</ArticleId><ArticleId IdType="pubmed">32328043</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Su H., Zhang T., Du J., Cui S., Yang F., Jin Q. Inhibition of Enterovirus 71 Replication by 7-Hydroxyflavone and Diisopropyl-Flavon7-yl Phosphate. PLoS ONE. 2014;9:e92565. doi: 10.1371/journal.pone.0092565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0092565</ArticleId><ArticleId IdType="pmc">PMC3963929</ArticleId><ArticleId IdType="pubmed">24664133</ArticleId></ArticleIdList></Reference><Reference><Citation>Galochkina A.V., Anikin V.B., Babkin V.A., Ostrouhova L.A., Zarubaev V.V. Virus-inhibiting activity of dihydroquercetin, a flavonoid from Larix sibirica, against coxsackievirus B4 in a model of viral pancreatitis. Arch. Virol. 2016;161:929–938. doi: 10.1007/s00705-016-2749-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-016-2749-3</ArticleId><ArticleId IdType="pubmed">26780775</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis L.E., Beckham J.D., Tyler K.L. North American Encephalitic Arboviruses. Neurol. Clin. 2008;26:727–757. doi: 10.1016/j.ncl.2008.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2008.03.012</ArticleId><ArticleId IdType="pmc">PMC2866042</ArticleId><ArticleId IdType="pubmed">18657724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesan K., Diwan A., Shankar S.K., Desai S.B., Sainani G.S., Katrak S.M. Chikungunya encephalomyeloradiculitis: Report of 2 cases with neuroimaging and 1 case with autopsy findings. Am. J. Neuroradiol. 2008;29:1636–1637. doi: 10.3174/ajnr.A1133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A1133</ArticleId><ArticleId IdType="pmc">PMC8118764</ArticleId><ArticleId IdType="pubmed">18566010</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta R., Gerardin P., de Brito C.A.A., Soares C.N., Ferreira M.L.B., Solomon T. The neurological complications of chikungunya virus: A systematic review. Rev. Med. Virol. 2018;28:e1978. doi: 10.1002/rmv.1978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1978</ArticleId><ArticleId IdType="pmc">PMC5969245</ArticleId><ArticleId IdType="pubmed">29671914</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson J., Waggoner J.J., Sahoo M.K., Grant P.M., Pinsky B.A. Encephalitis caused by Chikungunya virus in a traveler from the Kingdom of Tonga. J. Clin. Microbiol. 2014;52:3459–3461. doi: 10.1128/JCM.01288-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01288-14</ArticleId><ArticleId IdType="pmc">PMC4313184</ArticleId><ArticleId IdType="pubmed">24958800</ArticleId></ArticleIdList></Reference><Reference><Citation>Wielanek A.C., De Monredon J., El Amrani M., Roger J.C., Serveaux J.P. Guillain-Barré syndrome complicating a Chikungunya virus infection. Neurology. 2007;69:2105–2107. doi: 10.1212/01.wnl.0000277267.07220.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000277267.07220.88</ArticleId><ArticleId IdType="pubmed">18040016</ArticleId></ArticleIdList></Reference><Reference><Citation>Mota M.T.d.O., Estofolete C.F., Zini N., Terzian A.C.B., Gongora D.V.N., Maia I.L., Nogueira M.L. Transverse Myelitis as an Unusual Complication of Dengue Fever. Am. J. Trop. Med. Hyg. 2017;96:380–381. doi: 10.4269/ajtmh.16-0284.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.16-0284</ArticleId><ArticleId IdType="pmc">PMC5303040</ArticleId><ArticleId IdType="pubmed">27956656</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar J.J. Zika Virus and Other Emerging Arboviral Central Nervous System Infections. Contin. Lifelong Learn. Neurol. 2018;24:1512–1534. doi: 10.1212/CON.0000000000000652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000652</ArticleId><ArticleId IdType="pubmed">30273250</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollati M., Alvarez K., Assenberg R., Baronti C., Canard B., Cook S., Coutard B., Decroly E., de Lamballerie X., Gould E.A., et al. Structure and functionality in flavivirus NS-proteins: Perspectives for drug design. Antiviral Res. 2010;87:125–148. doi: 10.1016/j.antiviral.2009.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2009.11.009</ArticleId><ArticleId IdType="pmc">PMC3918146</ArticleId><ArticleId IdType="pubmed">19945487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Wu Z., Wang M., Cheng A. Innate immune evasion mediated by flaviviridae non-structural proteins. Viruses. 2017;9:291. doi: 10.3390/v9100291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v9100291</ArticleId><ArticleId IdType="pmc">PMC5691642</ArticleId><ArticleId IdType="pubmed">28991176</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakar F.A., Ng L.F.P. Nonstructural proteins of alphavirus—Potential targets for drug development. Viruses. 2018;10:71. doi: 10.3390/v10020071.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10020071</ArticleId><ArticleId IdType="pmc">PMC5850378</ArticleId><ArticleId IdType="pubmed">29425115</ArticleId></ArticleIdList></Reference><Reference><Citation>Narwal M., Singh H., Pratap S., Malik A., Kuhn R.J., Kumar P., Tomar S. Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site. Int. J. Biol. Macromol. 2018;116:451–462. doi: 10.1016/j.ijbiomac.2018.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2018.05.007</ArticleId><ArticleId IdType="pubmed">29730006</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastos M.d.S., Martins V.d.C.A., da Silva N.L., Jezine S., Pinto S., Aprigio V., Monte R.L., Fragoso S., Puccioni-Sohler M. Importance of cerebrospinal fluid investigation during dengue infection in Brazilian Amazonia Region. Mem. Inst. Oswaldo Cruz. 2019;114:e180450. doi: 10.1590/0074-02760180450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0074-02760180450</ArticleId><ArticleId IdType="pmc">PMC6319028</ArticleId><ArticleId IdType="pubmed">30540031</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiat T.S., Pippen R., Yusof R., Ibrahim H., Khalid N., Rahman N.A. Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease. Bioorg. Med. Chem. Lett. 2006;16:3337–3340. doi: 10.1016/j.bmcl.2005.12.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2005.12.075</ArticleId><ArticleId IdType="pubmed">16621533</ArticleId></ArticleIdList></Reference><Reference><Citation>Frabasile S., Koishi A.C., Kuczera D., Silveira G.F., Verri W.A., Dos Santos C.N.D., Bordignon J. The citrus flavanone naringenin impairs dengue virus replication in human cells. Sci. Rep. 2017;7:41864. doi: 10.1038/srep41864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41864</ArticleId><ArticleId IdType="pmc">PMC5291091</ArticleId><ArticleId IdType="pubmed">28157234</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi K., Lim T.-H., Rahim N.-A., Shu M.-H., Teoh B.-T., Sam S.-S., Danlami M.-B., Tan K.-K., Abubakar S. Extract of Scutellaria baicalensis inhibits dengue virus replication. BMC Complement. Altern. Med. 2013;13:91. doi: 10.1186/1472-6882-13-91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6882-13-91</ArticleId><ArticleId IdType="pmc">PMC3655864</ArticleId><ArticleId IdType="pubmed">23627436</ArticleId></ArticleIdList></Reference><Reference><Citation>Senthilvel P., Lavanya P., Kumar K.M., Swetha R., Anitha P., Bag S., Sarveswari S., Vijayakumar V., Ramaiah S., Anbarasu A. Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly. Bioinformation. 2013;9:889–895. doi: 10.6026/97320630009889.</Citation><ArticleIdList><ArticleId IdType="doi">10.6026/97320630009889</ArticleId><ArticleId IdType="pmc">PMC3842573</ArticleId><ArticleId IdType="pubmed">24307765</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonyasuppayakorn S., Saelee T., Visitchanakun P., Leelahavanichkul A., Hengphasatporn K., Shigeta Y., Thanh Huynh T.N., Hann Chu J.J., Rungrotmongkol T., Chavasiri W. Dibromopinocembrin and Dibromopinostrobin Are Potential Anti-Dengue Leads with Mild Animal Toxicity. Molecules. 2020;25:4154. doi: 10.3390/molecules25184154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25184154</ArticleId><ArticleId IdType="pmc">PMC7571160</ArticleId><ArticleId IdType="pubmed">32932762</ArticleId></ArticleIdList></Reference><Reference><Citation>Naccache S.N., Thézé J., Sardi S.I., Somasekar S., Greninger A.L., Bandeira A.C., Campos G.S., Tauro L.B., Faria N.R., Pybus O.G., et al. Distinct zika virus lineage in Salvador, Bahia, Brazil. Emerg. Infect. Dis. 2016;22:1788–1792. doi: 10.3201/eid2210.160663.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2210.160663</ArticleId><ArticleId IdType="pmc">PMC5038429</ArticleId><ArticleId IdType="pubmed">27448188</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu C.F., Chu L.W., Liao I.C., Simanjuntak Y., Lin Y.L., Juan C.C., Ping Y.H. The Mechanism of the Zika Virus Crossing the Placental Barrier and the Blood-Brain Barrier. Front. Microbiol. 2020;11:214. doi: 10.3389/fmicb.2020.00214.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.00214</ArticleId><ArticleId IdType="pmc">PMC7044130</ArticleId><ArticleId IdType="pubmed">32153526</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladwyn-Ng I., Cordón-Barris L., Alfano C., Creppe C., Couderc T., Morelli G., Thelen N., America M., Bessières B., Encha-Razavi F., et al. Stress-induced unfolded protein response contributes to Zika virus–associated microcephaly. Nat. Neurosci. 2017;21:63–71. doi: 10.1038/s41593-017-0038-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0038-4</ArticleId><ArticleId IdType="pubmed">29230053</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun S.R., Wassenaar T.M., Wanchai V., Patumcharoenpol P., Nookaew I., Ussery D.W. Suggested mechanisms for Zika virus causing microcephaly: What do the genomes tell us? BMC Bioinform. 2017;18:471. doi: 10.1186/s12859-017-1894-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-017-1894-3</ArticleId><ArticleId IdType="pmc">PMC5751795</ArticleId><ArticleId IdType="pubmed">29297281</ArticleId></ArticleIdList></Reference><Reference><Citation>Cataneo A.H.D., Kuczera D., Koishi A.C., Zanluca C., Silveira G.F., de Arruda T.B., Suzukawa A.A., Bortot L.O., Dias-Baruffi M., Verri W.A., et al. The citrus flavonoid naringenin impairs the in vitro infection of human cells by Zika virus. Sci. Rep. 2019;9:16348. doi: 10.1038/s41598-019-52626-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-52626-3</ArticleId><ArticleId IdType="pmc">PMC6841724</ArticleId><ArticleId IdType="pubmed">31705028</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahar Doan K.M., Humphreys J.E., Webster L.O., Wring S.A., Shampine L.J., Serabjit-Singh C.J., Adkison K.K., Polli J.W. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. J. Pharmacol. Exp. Ther. 2002;303:1029–1037. doi: 10.1124/jpet.102.039255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.102.039255</ArticleId><ArticleId IdType="pubmed">12438524</ArticleId></ArticleIdList></Reference><Reference><Citation>Jäger A., Saaby L. Flavonoids and the CNS. Molecules. 2011;16:1471–1485. doi: 10.3390/molecules16021471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules16021471</ArticleId><ArticleId IdType="pmc">PMC6259921</ArticleId><ArticleId IdType="pubmed">21311414</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardona F., Andrés-Lacueva C., Tulipani S., Tinahones F.J., Queipo-Ortuño M.I. Benefits of polyphenols on gut microbiota and implications in human health. J. Nutr. Biochem. 2013;24:1415–1422. doi: 10.1016/j.jnutbio.2013.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2013.05.001</ArticleId><ArticleId IdType="pubmed">23849454</ArticleId></ArticleIdList></Reference><Reference><Citation>Leclerc M., Dudonné S., Calon F. Can Natural Products Exert Neuroprotection without Crossing the Blood–Brain Barrier? Int. J. Mol. Sci. 2021;22:3356. doi: 10.3390/ijms22073356.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22073356</ArticleId><ArticleId IdType="pmc">PMC8037419</ArticleId><ArticleId IdType="pubmed">33805947</ArticleId></ArticleIdList></Reference><Reference><Citation>Solbrig M.V. Animal Models of CNS Viral Disease: Examples from Borna Disease Virus Models. Interdiscip. Perspect. Infect. Dis. 2010;2010:709791. doi: 10.1155/2010/709791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2010/709791</ArticleId><ArticleId IdType="pmc">PMC2829629</ArticleId><ArticleId IdType="pubmed">20204069</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamitani W., Ono E., Yoshino S., Kobayashi T., Taharaguchi S., Lee B.J., Yamashita M., Kobayashi T., Okamoto M., Taniyama H., et al. Glial expression of Borna disease virus phosphoprotein induces behavioral and neurological abnormalities in transgenic mice. Proc. Natl. Acad. Sci. USA. 2003;100:8969–8974. doi: 10.1073/pnas.1531155100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1531155100</ArticleId><ArticleId IdType="pmc">PMC166422</ArticleId><ArticleId IdType="pubmed">12857949</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J., Cho W.H., Barcelon E., Kim K.H., Hong J., Lee S.J. SARS-CoV-2 spike protein induces cognitive deficit and anxiety-like behavior in mouse via non-cell autonomous hippocampal neuronal death. Sci. Rep. 2022;12:5496. doi: 10.1038/s41598-022-09410-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-09410-7</ArticleId><ArticleId IdType="pmc">PMC8970073</ArticleId><ArticleId IdType="pubmed">35361832</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>